Aiosyn
Nijmegen AI pathology helps laboratories assess digital tissue biopsies faster and more consistently, including in cancer.
About
Aiosyn is a spin-off from the computational pathology group at Radboudumc. The software uses AI to inspect and characterize digital tissue images, measuring features that help pathologists in their assessment. Radboudumc implemented a quality control algorithm in clinical routine. Aiosyn is also developing applications for breast cancer and kidney diseases among others. The claim is modest: the software supports pathologists and can make analysis more consistent and efficient; ultimate responsibility for the diagnosis remains with the professional.
AI factor
AI recognizes patterns and quality problems in digital pathology images, supporting the pathologist.
Sources
Inspiration sourced from AI For Good. Not an Arnaldus customer case.